PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
30106130-6	2018	In addition, the results of a viability assay and Annexin V staining revealed that CPT-induced autophagy could protect lung cancer cells from programmed cell death.	Camptothecin	83-86	annexin A5	Homo sapiens	50-59	
23924470-5	2013	The binding of (99)Tc(m)-His10-Annexin V to apoptotic cells was validated in vitro using camptothecin-induced Jurkat cells.	Camptothecin	89-101	annexin A5	Homo sapiens	31-40	
21531294-3	2011	The binding of (99m)Tc-His(10)-annexin V to apoptosis was validated in vitro using camptothecin-induced Jurkat cells.	Camptothecin	83-95	annexin A5	Homo sapiens	31-40	
12485664-8	2003	The biological activity of radiolabelled annexin-V was tested in control and camptothecin-treated (i.e. apoptotic) human leukaemic HL60 cells.	Camptothecin	77-89	annexin A5	Homo sapiens	41-50	
14750127-2	2004	METHODS: Cells of the human promyelocytic HL-60 line treated with camptothecin (CPT) or ultraviolet light (UV) were labeled with fluorescein isothiocyanate-conjugated annexin V and prefixed with 1% methanol-free formaldehyde on ice, and their DNA was stained stoichiometrically with propidium iodide in the presence of digitonin.	Camptothecin	66-78	annexin A5	Homo sapiens	167-176	
14750127-2	2004	METHODS: Cells of the human promyelocytic HL-60 line treated with camptothecin (CPT) or ultraviolet light (UV) were labeled with fluorescein isothiocyanate-conjugated annexin V and prefixed with 1% methanol-free formaldehyde on ice, and their DNA was stained stoichiometrically with propidium iodide in the presence of digitonin.	Camptothecin	80-83	annexin A5	Homo sapiens	167-176	
12485664-10	2003	The binding of [125I]m-SIB labelled annexin-V to camptothecin treated cells was blocked (68%) by a 100-fold excess of unlabelled annexin-V.	Camptothecin	49-61	annexin A5	Homo sapiens	36-45	
12485664-10	2003	The binding of [125I]m-SIB labelled annexin-V to camptothecin treated cells was blocked (68%) by a 100-fold excess of unlabelled annexin-V.	Camptothecin	49-61	annexin A5	Homo sapiens	129-138	
10754512-3	2000	There have been some conflicting results concerning whether annexin V binds to camptothecin (CAM)-treated HL-60 cells, a commonly used model for apoptosis.	Camptothecin	79-91	annexin A5	Homo sapiens	60-69	
12052248-0	2002	Release of annexin V-binding membrane microparticles from cultured human umbilical vein endothelial cells after treatment with camptothecin.	Camptothecin	127-139	annexin A5	Homo sapiens	11-20	
12052248-5	2002	In contrast, induction of apoptosis with 5 microM camptothecin, documented by 60-70% desquamation of HUVEC culture, annexin V-binding to the cells and DNA-fragmentation, led to a release of annexin V-binding microparticles (approximately 80,000 MP/103 cells).	Camptothecin	50-62	annexin A5	Homo sapiens	116-125	
12052248-5	2002	In contrast, induction of apoptosis with 5 microM camptothecin, documented by 60-70% desquamation of HUVEC culture, annexin V-binding to the cells and DNA-fragmentation, led to a release of annexin V-binding microparticles (approximately 80,000 MP/103 cells).	Camptothecin	50-62	annexin A5	Homo sapiens	190-199	
12052248-10	2002	CONCLUSIONS: Camptothecin treated HUVEC released different populations of annexin V-binding membrane microparticles at early stage after proapoptotic stimulation before detection of phosphatidylserine exposure on the cells or DNA fragmentation.	Camptothecin	13-25	annexin A5	Homo sapiens	74-83	
10754512-3	2000	There have been some conflicting results concerning whether annexin V binds to camptothecin (CAM)-treated HL-60 cells, a commonly used model for apoptosis.	Camptothecin	93-96	annexin A5	Homo sapiens	60-69